Paper22869752
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.
Sanchez PE and 10 others. Proc Natl Acad Sci U S A, 2012. Cited by 541 papers, by iCite.
Cite this record
ConductScience Library. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Papers, record 22869752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22869752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Anticonvulsants | Major topic |
| Cognition | Major topic |
| Cognition Disorders | Major topic |
| Nerve Net | Major topic |
| Piracetam | Major topic |
| Synapses | Major topic |
| Amyloid beta-Protein Precursor | |
| Analysis of Variance | |
| Animals | |
| Blotting, Western | |
| Electroencephalography | |
| Humans | |
| Immunohistochemistry | |
| Levetiracetam | |
| Maze Learning | |
| Mice | |
| Mice, Transgenic |
Source PubMed
Grants14
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 AG023501 | NIA NIH HHS | United States | P50AG023501 | PubMed and NIH | NIH RePORTER |
| R01 AG011385 | NIA NIH HHS | United States | R01AG011385 | PubMed and NIH | NIH RePORTER |
| K23 AG038357 | NIA NIH HHS | United States | K23AG038357 | PubMed and NIH | NIH RePORTER |
| F32 AG039220 | NIA NIH HHS | United States | F32AG039220 | PubMed | NIH RePORTER |
| AG011385 | NIA NIH HHS | United States | R01AG011385 | PubMed and NIH | NIH RePORTER |
| AG022074 | NIA NIH HHS | United States | P01AG022074 | PubMed and NIH | NIH RePORTER |
| P01 AG022074 | NIA NIH HHS | United States | P01AG022074 | PubMed and NIH | NIH RePORTER |
| AG023501 | NIA NIH HHS | United States | P50AG023501 | PubMed and NIH | NIH RePORTER |
| NS065780 | NINDS NIH HHS | United States | P30NS065780 | PubMed and NIH | NIH RePORTER |
| RR18928-01 | NCRR NIH HHS | United States | PubMed | PubMed | |
| P30 NS065780 | NINDS NIH HHS | United States | P30NS065780 | PubMed and NIH | NIH RePORTER |
| R37 AG011385 | NIA NIH HHS | United States | R01AG011385 | PubMed and NIH | NIH RePORTER |
| C06 RR018928 | NCRR NIH HHS | United States | C06RR018928 | PubMed and NIH | NIH RePORTER |
| R37AG011385 | NIH | NIH RePORTER |
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02002819 | Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability | Background | ClinicalTrials.gov | |
| NCT03461861 | Network-Level Mechanisms for Preclinical Alzheimer's Disease Development | Background | ClinicalTrials.gov | |
| NCT03617497 | Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease | Background | ClinicalTrials.gov | |
| NCT04004702 | Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 23000687 | Neurodegenerative diseases: Anti-epileptic drug shows benefit in AD mouse model. | https://conductscience.org/library/papers/23000687 |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15555635 | Effects of distinct classes of N-methyl-D-aspartate receptor antagonists on seizures, axonal sprouting and neuronal loss in vitro: suppression by NR2B-selective antagonists. | Neuropharmacology | 2004 | https://conductscience.org/library/papers/15555635 | PubMed |
| 2 | 19204149 | Epilepsy and cognitive impairments in Alzheimer disease. | Arch Neurol | 2009 | https://conductscience.org/library/papers/19204149 | PubMed |
| 3 | 20032967 | Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment. | Neuropsychopharmacology | 2010 | https://conductscience.org/library/papers/20032967 | PubMed |
| 4 | 17785178 | Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. | Neuron | 2007 | https://conductscience.org/library/papers/17785178 | PubMed |
| 5 | 21113149 | Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. | Nature | 2011 | https://conductscience.org/library/papers/21113149 | PubMed |
| 6 | 19176798 | SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis. | J Neurosci | 2009 | https://conductscience.org/library/papers/19176798 | PubMed |
| 7 | 12576168 | Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. | Epilepsy Res | 2003 | https://conductscience.org/library/papers/12576168 | PubMed |
| 8 | 10818140 | High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. | J Neurosci | 2000 | https://conductscience.org/library/papers/10818140 | PubMed |
| 9 | 21228179 | Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. | J Neurosci | 2011 | https://conductscience.org/library/papers/21228179 | PubMed |
| 10 | 19230774 | Calcium signaling and neurodegenerative diseases. | Trends Mol Med | 2009 | https://conductscience.org/library/papers/19230774 | PubMed |
| 11 | 7499323 | Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7499323 | PubMed |
| 12 | 19829367 | Neuroscience: Alzheimer's disease. | Nature | 2009 | https://conductscience.org/library/papers/19829367 | PubMed |
| 13 | 21543591 | Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. | J Neurosci | 2011 | https://conductscience.org/library/papers/21543591 | PubMed |
| 14 | 17408599 | Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection. | Brain Res | 2007 | https://conductscience.org/library/papers/17408599 | PubMed |
| 15 | 16237174 | Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. | J Neurosci | 2005 | https://conductscience.org/library/papers/16237174 | PubMed |
| 16 | 21395360 | Levetiracetam: a review of its use in epilepsy. | Drugs | 2011 | https://conductscience.org/library/papers/21395360 | PubMed |
| 17 | 20348922 | Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. | Nat Med | 2010 | https://conductscience.org/library/papers/20348922 | PubMed |
| 18 | 19935655 | Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. | Nat Neurosci | 2009 | https://conductscience.org/library/papers/19935655 | PubMed |
| 19 | 9037091 | Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9037091 | PubMed |
| 20 | 18819729 | ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices. | Neurobiol Aging | 2010 | https://conductscience.org/library/papers/18819729 | PubMed |
Cited by362
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 541 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42951886 | Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42951886 | PubMed |
| 42875809 | Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/42875809 | PubMed |
| 42818781 | Structural Determinants of Synaptic Vesicle Protein 2C Ligand Selectivity and Their Impact on Dopamine Release. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818781 | PubMed |
| 42801635 | Co-activation of Selective Nicotinic Acetylcholine Receptor Subtypes Is Required for Neuroprotection against Alzheimer's Disease. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42801635 | PubMed |
| 42344858 | Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexes. | BMJ Neurol Open | 2026 | https://conductscience.org/library/papers/42344858 | PubMed |
| 42328935 | mTORC2-Nav1.2 signaling drives early hyperexcitability in Alzheimer's disease mouse model. | Channels (Austin) | 2026 | https://conductscience.org/library/papers/42328935 | PubMed |
| 42250220 | Impaired spatial coding and neuronal hyperactivity in the medial entorhinal cortex of aged APP knock-in mice. | Cell Rep | 2026 | https://conductscience.org/library/papers/42250220 | PubMed |
| 42146335 | Therapeutic targeting of fibrin-microglia interactions ameliorates Alzheimer's disease-related hyperexcitability and brain network dysfunction. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146335 | PubMed |
| 42082835 | Lamotrigine Improves Spatial Learning and Attenuates AD-Related Pathology in APP/PS1 Mice, with Possible Involvement of the cAMP/PKA/CREB Pathway. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42082835 | PubMed |
| 41987879 | Epilepsy and EEG abnormalities in neurodegenerative dementias: toward a system epilepsy framework. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41987879 | PubMed |
| 41933197 | Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis. | Nat Aging | 2026 | https://conductscience.org/library/papers/41933197 | PubMed |
| 41906332 | Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies. | Exp Neurobiol | 2026 | https://conductscience.org/library/papers/41906332 | PubMed |
| 41871415 | Tau pathology in epilepsy: emerging mechanisms and translational opportunities. | Brain | 2026 | https://conductscience.org/library/papers/41871415 | PubMed |
| 41834887 | Myoclonus in geriatric dogs and its association with canine cognitive dysfunction: an online survey. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/41834887 | PubMed |
| 41794826 | Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology. | Nat Commun | 2026 | https://conductscience.org/library/papers/41794826 | PubMed |
| 41766754 | Epilepsy and Alzheimer Disease: Epidemiologic, Clinical, Molecular, and Neuropathologic Convergences and Divergences. | Neurol Clin Pract | 2026 | https://conductscience.org/library/papers/41766754 | PubMed |
| 41743466 | ZCCHC17: a target for synaptic dysfunction and neuronal excitability in Alzheimer's disease. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41743466 | PubMed |
| 41735175 | Exploring Linalool-Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition. | Phytother Res | 2026 | https://conductscience.org/library/papers/41735175 | PubMed |
| 41673049 | A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing. | Sci Rep | 2026 | https://conductscience.org/library/papers/41673049 | PubMed |
| 41671338 | Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models. | Sci Transl Med | 2026 | https://conductscience.org/library/papers/41671338 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22869752
GET https://conductscience.org/api/papers/v1/22869752/references?page=2